<DOC>
	<DOC>NCT02980315</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of the designed LMP1－CAR －T cells and determine whether the CAR-T cells are effective in the treatment of EBV associated malignant tumors.</brief_summary>
	<brief_title>A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application</brief_title>
	<detailed_description>Half of the patients will treat with LMP1-CAR-T cells,while the other half will receive a placebo.During the time of the treatment ,we will supervise the side effect of treated group.At last we compare the survival rate and health condition of the two groups.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Clinical diagnosis of nasopharyngeal carcinoma •pregnant woman severe autoimmune diseases serious infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>EBV related cancers</keyword>
</DOC>